Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions
Metabolic SyndromeDyslipidaemia
Interventions
DRUG

nicotine acid

16 weeks, randomisation with 500 mg, after 4 weeks elevation of 1000 mg, after week 8 to week 16 1500 mg study medication

DRUG

placebo

16 weeks treatment with placebo

Trial Locations (1)

01307

GWT-TUD GmbH, Centre for Clinical Studies, Dresden

All Listed Sponsors
collaborator

Technische Universität Dresden

OTHER

collaborator

University of Regensburg

OTHER

lead

GWT-TUD GmbH

OTHER

NCT00659321 - Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter